Get started
Author

Lucy Heinemann

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
2008 · C L White, K R Twigger, et al. · Gene Therapy · 151
Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
2008 · Katie Twigger, Laura Vidal, et al. · Clinical Cancer Research · 104
Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma
2009 · Hardev S. Pandha, Lucy Heinemann, et al. · Clinical Cancer Research · 98
PDF
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
2011 · Lucy Heinemann, Guy R Simpson, et al. · BMC Cancer · 70
PDF
Reovirus: Viral Therapy for Cancer ‘as Nature Intended’
2008 · C. Comins, L. Heinemann, et al. · Clinical Oncology · 56
The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis
2010 · Lucy Heinemann, Guy R Simpson, et al. · Molecular Therapy · 25
PDF
Effective Induction of Type 1 Helper IgG 2a and Cytotoxic T-Cell Responses in Mice Following Immunization with Human Papillomavirus Type 16 E2 in MF59
2008 · Lucy Heinemann, Lauren Woodfield, et al. · Viral Immunology · 8
Flow cytometric quantitation of the protective efficacy of dendritic cell based vaccines in a human papillomavirus type 16 murine challenge model
2003 · Lucy Heinemann, Stephanie Dillon, et al. · Journal of Virological Methods · 4
Supplementary Figures S1-S4 from Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
2023 · Katie Twigger, Laura Vidal, et al.
Data from Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
2023 · Katie Twigger, Laura Vidal, et al.
Data from Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
2023 · Katie Twigger, Laura Vidal, et al.
Supplementary Figures S1-S4 from Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy
2023 · Katie Twigger, Laura Vidal, et al.
PDF
Synergistic Anti-Tumor Activity of Oncolytic Reovirus and Docetaxel in a PC-3 Prostate Cancer Mouse Model
2008 · Lucy Heinemann, Timothy Kottke, et al. · Open Research (University of Surrey)
308 POSTER Synergistic anti-tumour activity of oncolytic Reovirus and cisplatin in a B16.F10 mouse melanoma model
2008 · L. Heinemann, G. Simpson, et al. · European Journal of Cancer Supplements
Works count: 15
Citation count: 516
H-index: 7
I10-index: 6
Year
Topic
Type